Keyword results: unquoted

Collapsing-Reactor

Neil Woodford Redemptions Watch: it is a mess

Yesterday the FTSE All-Share (Neil Woodford’s benchmark for his Equity Income and Income Focus funds) closed almost flat on the day. Happily for Neil his Income Focus fund put on 0.23% in NAV per unit and Equity Income put on 0.57%. although the reported figures are still distorted by the continuing suspension of Eddie Stobart (ESL) after  its shocking news earlier in the week.

PREMIUM CONTENT

Woodford Dog BenevolentAI: as predicted......but it is good news really!

The Sunday Times carries a scoop that Neil Woodford's play on revolutionising biotech, BenevolentAI - held in both WPCT and his Equity Income Fund - is being written down because of a fundraise. Of course, ShareProphets worked it out a few days ago when WPCT announced a writedown to an un-named stock but the Sunday Times has it confirmed. 

Subscribe to ShareProphets to access Premium Content
Crime-Scene
PREMIUM CONTENT

Is this a slam-dunk breach of the rules by Woodford? The Al Capone solution

Andrew Bailey, the head of the FCA, has complained bitterly that Neil Woodford followed the letter, but not the spirit, of the rules in relation to the unquoted holdings within his Equity Income Fund, according to The Telegraph which was reporting on the FCA’s annual public meeting in London on Wednesday.

Subscribe to ShareProphets to access Premium Content

And today’s Neil Woodford disaster is……..the equity income fund

Last night Woodford Investment Management released its latest update for the Woodford Equity Income Fund, to 31 December 2018. The fund had fallen to £4.98 billion as at 30 November 2018. At year end it had slipped again – to £4.67 billion. Oopsadaisie Neil, another £310 million gone!

PREMIUM CONTENT

Woodford – a small detail shows what a disaster is going on: are we almost at end game for Neil?

Woodford Patient Capital Trust  (WPCT)or his flagship Equity Income Fund? It is hard to know where to start for we have disastrous news from both today. How close are we to end game for Neil Woodford, a man happy to be described as Britain's Buffett.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Purplebricks – purple faces at Woodford

ShareProphets has been very wary of AIM-listed Purplebricks (PURP) ever since its IPO at the end of 2015. The business model looks questionable, given the state of the UK and global housing markets, and there has been plenty of controversy over its business practices of suppressing criticism. Add to that the persistent offloading of stock by insiders and one really wonders how well this disruptor will perform. But Neil Woodford has been buying like the shares are going out of fashion…which they are!

Subscribe to ShareProphets to access Premium Content

Woodford Patient Capital Trust and Industrial Heat – this hilarity has made my day

Just when you don’t think that the goings-on at Woodford Patient Capital Trust (WPCT) can get any more surprising, an RNS comes out of nowhere to make everything right in the world, relating to the unloved holding Industrial Heat. It seems that Neil Woodford can bend the laws of physics after all!

PREMIUM CONTENT

Woodford Patient Capital Trust: The Big Short (July update) – Is the Equity Income Fund bending the rules again?

There is good news for Woodford Patient Capital Trust (WPCT) in the end-July portfolio listings that came out yesterday, ironically due to a bit of help from the Woodford’s flagship fund, the Equity Income Fund. More interestingly, I think I have finally worked out how the Equity Income Fund is getting round its 10% unquoted stock limits which makes shocking reading if correct.

Subscribe to ShareProphets to access Premium Content
PREMIUM CONTENT

Woodford Patient Capital Trust: The Big Short (June update - WPCT) – Um, Neil, what do we do now?

Having looked at Woodford’s Equity Income Fund earlier, I will now turn to Woodford Patient Capital Trust (WPCT) which as ever, even though the goalposts keep moving, is up against its limits and with the portfolio remaining awash with cash guzzlers, I’m struggling to understand how Neil Woodford gets out of the mess.

Subscribe to ShareProphets to access Premium Content

Woodford Patient Capital Trust: The Big Short (June update - Equity Income Fund) – Legal & General jettisoned in bid to keep hot air balloon afloat

With the end-June portfolio listings coming out yesterday, I thought I would update with a couple of pieces looking at each of the two major funds. First up, I’ll look at the flagship fund, the Equity Income Fund, where continuing redemptions necessitate exiting one of the better stocks completely leaving a greater proportion of dross behind.

Woodford Patient Capital Trust: The Big Short (March updates) – WTF happened to the “hard” 10% unquoted limit at the Equity Income Fund?

There’s been a lot to comment on relating to Woodford Capital Patient Trust (WPCT) recently but with the March portfolio updates for all of Woodford’s funds finally being published on Monday, I thought I should get my updates out as Woodford appears to have been a bit preoccupied to do so with a minor biotech blip and the like.

Woodford Patient Capital Trust: GOTCHA – Investment Policy WAS changed: an absolute scandal!

Following on from my piece on Sunday in which I suspected that Woodford had covertly changed the Investment Policy for Woodford Patient Capital Trust (WPCT), it was confirmed this morning in its full year results. This is an absolute disgrace and shareholders should get on to their lawyers.

UPDATED: Neil Woodford - the big question panicking NEDS must ask him about Woodford Patient Capital Trust

UPDATED: Over the weekend I revealed a potential nuclear landmine that could well blow up the Woodford Patient Capital Trust (WPCT).The bad news for the asleep at the wheel nmot so independent NEDS at the Trust is that I have found two more landmines which have been averted but are there more?

Neil Woodford - now about the missing dividends and another thing

I gather that Neil Woodford's office has been busy dealing with questions relating to our most excellent series of articles and podcasts over Christmas. I have been made aware of its responses which are detailed but still leave me feeling incredibly unsettled on two major factors.

PREMIUM CONTENT

Woodford Patient Capital Trust: The Big Short (Appendix 2) – A look at the detail of the strange Benevolent AI transactions

I alluded to the swapping of the Benevolent AI stock between the two Woodford funds in my early chapters of The Big Short looking at Woodford Patient Capital Trust (WPCT) but there are so many odd aspects to the saga going back a few years that it merits an Appendix to itself as it raises a number of serious additional questions for the Board in my view.

Subscribe to ShareProphets to access Premium Content

Woodford Patient Capital Trust: The Big Short (Chapter 3) – Concerns over its aggressive valuation policy

Having looked at the unquoted risk and the level of debt and connected liquidity issues within the Woodford Patient Capital Trust (WPCT), it is time to look at the tricky topic of valuation policy as it looks to me as if Woodford is taking a particularly aggressive approach, albeit a flexible one, to the valuation of the unquoted stocks (almost all the fund!) that casts further doubts on the underlying NAV.

PREMIUM CONTENT

Woodford Patient Capital Trust: The Big Short (Chapter 1) – Huge unquoted risk and a shocking conflict of interest

I started my festive series on The Big Short, namely Woodford Patient Capital Trust (WPCT) earlier by providing some wider context about some of the challenges Woodford faces particularly with his flagship fund, the Equity Income Fund, but let’s get into the details of WPCT itself. I’ll start with the ever increasing size of its unquoted portfolio and what appears to me to be a massive conflict of interest.

Subscribe to ShareProphets to access Premium Content
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|